Modulated expression of adhesion, migration and activation molecules may predict the degree of response in chronic lymphocytic leukemia patients treated with ibrutinib plus rituximab

• Nadia Peragine,
• Maria Stefania De Propris,
• Stefania Intoppa,
• Maria Laura Milani,
• Paola Mariglia,
• Francesca Romana Mauro,
• Sara Raponi,
• Stefano Soddu,
• Antonio Cuneo,
• Gian Matteo Rigolin,
• Ilaria Del Giudice,
• Robin Foà,
• Anna Guarini

Affiliations

Nadia Peragine

Hematology, Department of Translational and Precision Medicine, ‘Sapienza’ University, Rome

Maria Stefania De Propris

Hematology, Department of Translational and Precision Medicine, ‘Sapienza’ University, Rome

Stefania Intoppa

Hematology, Department of Translational and Precision Medicine, ‘Sapienza’ University, Rome

Maria Laura Milani

Hematology, Department of Translational and Precision Medicine, ‘Sapienza’ University, Rome

Paola Mariglia

Hematology, Department of Translational and Precision Medicine, ‘Sapienza’ University, Rome

Francesca Romana Mauro

Hematology, Department of Translational and Precision Medicine, ‘Sapienza’ University, Rome

Sara Raponi

Hematology, Department of Translational and Precision Medicine, ‘Sapienza’ University, Rome

Stefano Soddu

Italian Group for Adult Hematologic Diseases (GIMEMA) Foundation, Rome

Antonio Cuneo

Hematology, Department of Medical Sciences, University of Ferrara, Ferrara

Gian Matteo Rigolin

Hematology, Department of Medical Sciences, University of Ferrara, Ferrara

Ilaria Del Giudice

Hematology, Department of Translational and Precision Medicine, ‘Sapienza’ University, Rome

Robin Foà

Hematology, Department of Translational and Precision Medicine, ‘Sapienza’ University, Rome

Anna Guarini

Department of Molecular Medicine, “Sapienza” University, Rome, Italy